Sponsors (4)
The bill narrows and clarifies permissible chimera research to reduce ethical and safety risks, but does so at the expense of slowing some biomedical research, imposing compliance burdens, and potentially delaying or foreclosing future treatments for patients.
Researchers and hospitals gain clearer legal boundaries on creating human-animal chimeras, reducing uncertainty about what research is permissible.
Patients and the general public face potentially reduced bioethical and safety risks if certain risky chimera research is prohibited.
Patients with chronic conditions may experience delays or loss of access to future treatments that could rely on chimera-derived models or therapies.
Scientists and medical researchers could face restrictions that slow biomedical research and limit development of therapies using chimera models.
Hospitals and research institutions may incur new compliance costs and face legal uncertainty until prohibited activities and penalties are clearly defined.
Based on analysis of 3 sections of legislative text.
Names the Act and directs insertion of a new criminal-code chapter to prohibit certain human-animal chimeras, but provides no substantive prohibitions, definitions, penalties, or effective date.
Introduced March 14, 2025 by Christopher Henry Smith · Last progress March 14, 2025
Creates a short title and attempts to add a new criminal-code chapter that would prohibit certain human-animal chimeras, but does not include the substantive text of that prohibition. The bill updates the table of chapters in title 18, U.S. Code, but provides no definitions, prohibited acts, penalties, enforcement authority, exceptions, or effective date in the text provided.